collection
Collections Neurotransmitters and related ...

Neurotransmitters and related Papers : medical and naturopahic

https://read.qxmd.com/read/36721868/qualitative-insights-in-item-development-for-a-comprehensive-and-inclusive-measure-of-recovery-capital
#1
JOURNAL ARTICLE
Elizabeth Bowen, Andrew Irish, Charles LaBarre, Nicole Capozziello, Thomas Nochajski, Robert Granfield
BACKGROUND: Item specification is foundational to measurement development but rarely reported in depth. We address this gap by explicating our use of qualitative methods to ground and develop items for a new recovery capital measure, the Multidimensional Inventory of Recovery Capital. METHOD: We recruited a diverse sample of service providers ( n = 9) and people in recovery from alcohol problems ( n = 23) to provide feedback on an item pool assessing social, human, physical, community, and cultural capital...
2022: Addiction Research & Theory
https://read.qxmd.com/read/36185696/the-antidepressant-effects-and-serum-metabonomics-of-bifid-triple-viable-capsule-in-a-rat-model-of-chronic-unpredictable-mild-stress
#2
JOURNAL ARTICLE
Qinpeng Bu, Jingkai Zhang, Xiang Guo, Yifei Feng, Huan Yan, Weimin Cheng, Zhitao Feng, Meiqun Cao
BACKGROUND: Probiotics have shown potential antidepressant effects. This study evaluated the effect and probable mechanisms of bifid triple viable capsules (BTVCs) on a rat model of chronic unpredictable mild stress (CUMS). MATERIALS AND METHODS: Rats were randomly divided into Normal, CUMS model, fluoxetine hydrochloride (FLX), BTVCs, and FLX+BTVCs groups. Depressive-like behaviours, pathological changes in the hippocampus, changes in serum metabolites and potential biomarkers, and metabolic pathways were detected via behavioural tests, haematoxylin-eosin staining, nissl staining, non-targetted metabolomics, and ingenuity pathway analysis (IPA)...
2022: Frontiers in Nutrition
https://read.qxmd.com/read/36736919/gut-brain-axis-through-the-lens-of-gut-microbiota-and-their-relationships-with-alzheimer-s-disease-pathology-review-and-recommendations
#3
JOURNAL ARTICLE
Krishaa L, Ted Kheng Siang Ng, Hai Ning Wee, Jianhong Ching
Alzheimer's disease (AD) is a neurodegenerative disorder that affects millions of people worldwide. Growing evidence suggests that the gut microbiome (GM) plays a pivotal role in the pathogenesis of AD through the microbiota-gut-brain axis (MGB). Alterations in GM composition and diversity have been observed in both animal models and in human patients with AD. GM dysbiosis has been implicated in increased intestinal permeability, blood-brain barrier (BBB) impairment, neuroinflammation and the development of hallmarks of AD...
April 2023: Mechanisms of Ageing and Development
https://read.qxmd.com/read/36774727/artificial-intelligence-in-multi-objective-drug-design
#4
REVIEW
Sohvi Luukkonen, Helle W van den Maagdenberg, Michael T M Emmerich, Gerard J P van Westen
The factors determining a drug's success are manifold, making de novo drug design an inherently multi-objective optimisation (MOO) problem. With the advent of machine learning and optimisation methods, the field of multi-objective compound design has seen a rapid increase in developments and applications. Population-based metaheuris-tics and deep reinforcement learning are the most commonly used artificial intelligence methods in the field, but recently conditional learning methods are gaining popularity. The former approaches are coupled with a MOO strat-egy which is most commonly an aggregation function, but Pareto-based strategies are widespread too...
April 2023: Current Opinion in Structural Biology
https://read.qxmd.com/read/36748019/drug-synergism-as-the-basis-of-rational-neuroprotection
#5
JOURNAL ARTICLE
M V Putilina, N V Teplova
Optimization of the choice of neuroprotective therapy regimens in patients with cerebrovascular diseases (CVD), taking into account the synergism of drug interactions, is a basic approach in clinical practice. Unfortunately, modern pharmacology has no unified way of establishing synergistic spectra of drug actions, which would allow systematic investigation of the effects of combinations of drugs. An approach based on studying detailed mechanisms of action suggested combinations of drugs with the greatest possible synergism (by summation and potentiation of effects) for various directions in the treatment of neurological diseases...
2022: Neuroscience and Behavioral Physiology
https://read.qxmd.com/read/36750905/behavioral-biochemical-and-histopathological-toxic-profiles-induced-by-sub-chronic-cannabimimetic-win55-212-2-administration-in-mice
#6
JOURNAL ARTICLE
Ghada A Omran, Eman S H Abd Allah, Sherine Ahmed Mohammed, Doaa M El Shehaby
WIN55, 212-2 mesylate is a synthetic cannabinoid (SC) agonist of CB1 and CB2 receptors with much higher affinity to CB1 receptor than tetrahydrocannabinol and many potential therapeutic effects. Few studies have evaluated SCs effects on more complex animal behavior and sex differences in cannabinoids toxicology. The current study was undertaken for determination of behavioral (Open Field test), biochemical (liver and kidney function test plus GABA & Glutamate levels), histopathological and CB1 immunohistochemistry risks of sub-chronic administration of SC WIN55, 212-2 mesylate in male and female mice...
February 7, 2023: BMC Pharmacology & Toxicology
https://read.qxmd.com/read/36425018/psychopharmacological-approaches-to-a-case-of-treatment-resistant-adolescent-depression
#7
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
November 2022: Journal of the Canadian Academy of Child and Adolescent Psychiatry
https://read.qxmd.com/read/36551821/alternative-pharmacological-strategies-for-the-treatment-of-alzheimer-s-disease-focus-on-neuromodulator-function
#8
REVIEW
Grace Cunliffe, Yi Tang Lim, Woori Chae, Sangyong Jung
Alzheimer's disease (AD) is a neurodegenerative disorder, comprising 70% of dementia diagnoses worldwide and affecting 1 in 9 people over the age of 65. However, the majority of its treatments, which predominantly target the cholinergic system, remain insufficient at reversing pathology and act simply to slow the inevitable progression of the disease. The most recent neurotransmitter-targeting drug for AD was approved in 2003, strongly suggesting that targeting neurotransmitter systems alone is unlikely to be sufficient, and that research into alternate treatment avenues is urgently required...
November 28, 2022: Biomedicines
https://read.qxmd.com/read/36510616/the-american-society-of-pain-and-neuroscience-aspn-evidence-based-clinical-guideline-of-interventional-treatments-for-low-back-pain
#9
REVIEW
Dawood Sayed, Jay Grider, Natalie Strand, Jonathan M Hagedorn, Steven Falowski, Christopher M Lam, Vinicius Tieppo Francio, Douglas P Beall, Nestor D Tomycz, Justin R Davanzo, Rohit Aiyer, David W Lee, Hemant Kalia, Soun Sheen, Mark N Malinowski, Michael Verdolin, Shashank Vodapally, Alexios Carayannopoulos, Sameer Jain, Nomen Azeem, Reda Tolba, George C Chang Chien, Priyanka Ghosh, Anthony J Mazzola, Kasra Amirdelfan, Krishnan Chakravarthy, Erika Petersen, Michael E Schatman, Timothy Deer
INTRODUCTION: Painful lumbar spinal disorders represent a leading cause of disability in the US and worldwide. Interventional treatments for lumbar disorders are an effective treatment for the pain and disability from low back pain. Although many established and emerging interventional procedures are currently available, there exists a need for a defined guideline for their appropriateness, effectiveness, and safety. OBJECTIVE: The ASPN Back Guideline was developed to provide clinicians the most comprehensive review of interventional treatments for lower back disorders...
2022: Journal of Pain Research
https://read.qxmd.com/read/35543081/rapid-changes-in-illegally-manufactured-fentanyl-products-and-prices-in-the-united-states
#10
JOURNAL ARTICLE
Beau Kilmer, Bryce Pardo, Toyya A Pujol, Jonathan P Caulkins
BACKGROUND AND AIMS: Synthetic opioids, mostly illegally manufactured fentanyl (IMF), were mentioned in 60% of United States (US) drug overdose deaths in 2020, with dramatic variation across states that mirrors variation in IMF supply. However, little is known about IMF markets in the United States and how they are changing. Researchers have previously used data from undercover cocaine, heroin, and methamphetamine purchases and seizures to examine how their use and related harms respond to changes in price and availability...
October 2022: Addiction
https://read.qxmd.com/read/36462635/the-ameliorative-effects-and-mechanisms-of-abscisic-acid-on-learning-and-memory
#11
REVIEW
Ping Liao, Qing-Yun Wu, Sen Li, Kai-Bin Hu, Hui-Lin Liu, Hai-Yan Wang, Zai-Yun Long, Xiu-Min Lu, Yong-Tang Wang
Abscisic acid (ABA), a conserved hormone existing in plants and animals, not only regulates blood glucose and inflammation but also has good therapeutic effects on obesity, diabetes, atherosclerosis and inflammatory diseases in animals. Studies have shown that exogenous ABA can pass the blood-brain barrier and inhibit neuroinflammation, promote neurogenesis, enhance synaptic plasticity, improve learning, memory and cognitive ability in the central nervous system. At the same time, ABA plays a crucial role in significant improvement of Alzheimer's disease, depression, and anxiety...
February 15, 2023: Neuropharmacology
https://read.qxmd.com/read/36462602/baicalein-exerts-anxiolytic-and-antinociceptive-effects-in-a-mouse-model-of-posttraumatic-stress-disorder-involvement-of-the-serotonergic-system-and-spinal-delta-opioid-receptors
#12
JOURNAL ARTICLE
Lina Ruan, Kaiyu Guan, Yue Wang, Ming Gu, Yue Chen, Lisha Cai, Ruixuan Ye, Zhengwei Huang, Anqi Guo, Zhengkang Su, Xi Li, Jianchun Pan
Post-traumatic stress disorder (PTSD) is a serious mental disease featured by a stress dysfunction that occurs after an individual has faced intense mental stress, often accompanied by anxiety and chronic pain. Currently, the mainstream drug for PTSD is serotonin reuptake inhibitors (SSRIs), however, their pain management for patients is limited. Baicalein, a Chinese traditional herbal medicine, has shown promising results in treating anxiety, depression, and pain. In this study, we found that baicalein may alleviate single prolonged stress (SPS)-induced PTSD-like behaviors in mice without altering baseline nociceptive sensitivity or activity...
March 2, 2023: Progress in Neuro-psychopharmacology & Biological Psychiatry
https://read.qxmd.com/read/36455638/chronic-pain-in-alzheimer-s-disease-endocannabinoid-system
#13
REVIEW
Henry Blanton, P Hemachandra Reddy, Khalid Benamar
Chronic pain, one of the most common reasons adults seek medical care, has been linked to restrictions in mobility and daily activities, dependence on opioids, anxiety, depression, sleep deprivation, and reduced quality of life. Alzheimer's disease (AD), a devastating neurodegenerative disorder (characterized by a progressive impairment of cognitive functions) in the elderly, is often co-morbid with chronic pain. AD is one of the most common neurodegenerative disorders in the aged population. The reported prevalence of chronic pain is 45...
February 2023: Experimental Neurology
https://read.qxmd.com/read/36470445/alternative-role-of-glucagon-like-peptide-1-receptor-agonists-in-neurodegenerative-diseases
#14
REVIEW
Shang-Der Chen, Yao-Chung Chuang, Tsu-Kung Lin, Jenq-Lin Yang
Aging is a crucial risk factor for common neurodegenerative diseases, such as Alzheimer's disease (AD) and Parkinson's disease (PD). Limited options are available for the treatment of age-related, multiple pathogenic mechanism-contributed diseases that usually advance to irreversible conditions with severe neurological deficits and result in a heavy socioeconomic burden on patients, families, and society. A therapy that decelerates disease progression and reduces the socioeconomic burden stemming from these diseases is required...
January 5, 2023: European Journal of Pharmacology
https://read.qxmd.com/read/36255671/cells-of-the-central-nervous-system-an-overview-of-their-structure-and-function
#15
JOURNAL ARTICLE
John W Bigbee
The central nervous system is the last major organ system in the vertebrate body to yield its cellular structure, due to the complexity of its cells and their interactions. The fundamental unit of the nervous system is the neuron, which forms complex circuits that receive and integrate information and generate adaptive responses. Each neuron is composed of an input domain consisting of multiple dendrites along with the cell body, which is also responsible for the majority of macromolecule synthesis for the cell...
2023: Advances in Neurobiology
https://read.qxmd.com/read/36171828/psychedelics-their-limited-understanding-and-future-in-the-treatment-of-chronic-pain
#16
REVIEW
Vedant N Hedau, Ashish P Anjankar
Psychedelics are hallucinogenic drugs that alter the state of consciousness substantially. They bring about psychological, auditory, and visual changes. The psychedelics act on the brain, implying that they have a powerful psychological impact. One of the main factors contributing to disability worldwide is pain. The majority of people deal with pain on a daily basis. Living with chronic pain affects daily life and has social implications. Chronic pain can be associated with any disease that may be genetic, idiopathic, or traumatic...
August 2022: Curēus
https://read.qxmd.com/read/35965783/glucagon-like-peptide-1-and-glucose-dependent-insulinotropic-peptide-hormones-and-novel-receptor-agonists-protect-synapses-in-alzheimer-s-and-parkinson-s-diseases
#17
REVIEW
Christian Hölscher
Glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) are peptide hormones and growth factors. A major pathological feature of both Alzheimer's dis-ease (AD) and Parkinson's disease (PD) is the loss of synaptic transmission in the cortex in AD and the loss of dopaminergic synapses in the nigra-striatal dopaminergic projection. Several studies demonstrate that GLP-1 and GIP receptor agonists protect synapses and synaptic transmission from the toxic events that underlie AD and PD...
2022: Frontiers in Synaptic Neuroscience
https://read.qxmd.com/read/25843781/gamma-hydroxybutyrate-ghb-gamma-butyrolactone-gbl-and-1-4-butanediol-1-4-bd-bdo-a-literature-review-with-a-focus-on-uk-fatalities-related-to-non-medical-use
#18
REVIEW
John M Corkery, Barbara Loi, Hugh Claridge, Christine Goodair, Ornella Corazza, Simon Elliott, Fabrizio Schifano
Misuse of gamma hydroxybutrate (GHB) and gamma butyrolactone (GBL) has increased greatly since the early 1990s, being implicated in a rising number of deaths. This paper reviews knowledge on GHB and derivatives, and explores the largest series of deaths associated with their non-medical use. Descriptive analyses of cases associated with GHB/GBL and 1,4-butanediol (1,4-BD) use extracted from the UK's National Programme on Substance Abuse Deaths database. From 1995 to September 2013, 159 GHB/GBL-associated fatalities were reported...
June 2015: Neuroscience and Biobehavioral Reviews
https://read.qxmd.com/read/29383983/the-role-of-the-gut-microbiota-in-schizophrenia-current-and-future-perspectives
#19
REVIEW
Daniela Rodrigues-Amorim, Tania Rivera-Baltanás, Benito Regueiro, Carlos Spuch, María Elena de Las Heras, Raul Vázquez-Noguerol Méndez, Maria Nieto-Araujo, Carolina Barreiro-Villar, Jose Manuel Olivares, Roberto Carlos Agís-Balboa
OBJECTIVES: Schizophrenia is a poorly understood chronic disease. Its pathophysiology is complex, dynamic, and linked to epigenetic mechanisms and microbiota involvement. Nowadays, correlating schizophrenia with the environment makes sense owing to its multidimensional implications: temporal and spatial variability. Microbiota involvement and epigenetic mechanisms are factors that are currently being considered to better understand another dimension of schizophrenia. METHODS: This review summarises and discusses currently available information, focussing on the microbiota, epigenetic mechanisms, technological approaches aimed at performing exhaustive analyses of the microbiota, and psychotherapies, to establish future perspectives...
December 2018: World Journal of Biological Psychiatry
https://read.qxmd.com/read/30204559/anxiolytics-targeting-gaba-a-receptors-insights-on-etifoxine
#20
REVIEW
Pierrick Poisbeau, Geraldine Gazzo, Laurent Calvel
OBJECTIVES: Anxiety and adjustment disorders are among the most prevalent mental health conditions. This review focuses on γ-aminobutyric acid receptor type A (GABAA R)-mediated anxiolysis, describing the action of both endogenous and exogenous modulators of GABAA R. Future directions and innovative strategies to alleviate anxiety symptoms are discussed, with a particular emphasis on etifoxine. METHODS: We used available data from the recent literature to update the mode of action of anxiolytics...
2018: World Journal of Biological Psychiatry
label_collection
label_collection
2000
1
2
2019-03-09 07:06:03
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.